Last reviewed · How we verify
Wulingsan co-decoction granules — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Wulingsan co-decoction granules (Wulingsan co-decoction granules) — Jiangsu Famous Medical Technology Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Wulingsan co-decoction granules TARGET | Wulingsan co-decoction granules | Jiangsu Famous Medical Technology Co., Ltd. | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Wulingsan co-decoction granules CI watch — RSS
- Wulingsan co-decoction granules CI watch — Atom
- Wulingsan co-decoction granules CI watch — JSON
- Wulingsan co-decoction granules alone — RSS
Cite this brief
Drug Landscape (2026). Wulingsan co-decoction granules — Competitive Intelligence Brief. https://druglandscape.com/ci/wulingsan-co-decoction-granules. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab